Allergy/Immunology

• Immunotherapy Research in Prostate Cancer

• April 19, 2013
• Susan F. Slovin, MD, PhD, an associate member in the Genitourinary Oncology Service at the Memorial Sloan-Kettering Cancer Center, reviews the clinical ......More »

• PD1 Inhibitors Immunotherapy in Cancer Care

• March 23, 2013
• Jeff Infante, MD, Director of Drug Development Unit at the Sarah Cannon Research Institute discusses breakthroughs in PD1 Inhibitors & Immunotherapy in ......More »

• House Dust Mite Extract for Immunotherapy Video Abstract

• March 16, 2013
• Video abstract of review paper "Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy" published in the open access ......More »

• A Novel TwoStep Immunotherapy for Ovarian Cancer

• March 8, 2013
• Dr. Lana Kandalaft on a Novel TwoStep Immunotherapy for Ovarian Cancer. Lana Kandalaft pharmd MTR phd director of clinical development in the Ovarian ......More »

• Dr Gettinger on the Evolution of Immunotherapies in Lung Cancer

• January 18, 2013
• Scott Gettinger, MD, associate professor of medicine (medical oncology), Yale School of Medicine, explains the development of immunotherapies in lung ......More »

• PD1 Inhibitor BMS936558 in NonSmall Cell Lung Cancer

• December 14, 2012
• Scott Gettinger, MD, associate professor of medicine (medical oncology), Yale School of Medicine, discusses updated results from a phase I trial that ......More »

• Challenges Facing Immunotherapy

• November 9, 2012
• Michael Rotkowitz, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, says that one of the main challenges and ......More »

• Ipilimumab Plus Dacarbazine for Metastatic Melanoma

• October 27, 2012
• Michael Rotkowitz, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, discusses a phase III trial that examined ......More »

• Managing the Side Effects of Ipilimumab and Vemurafenib

• October 27, 2012
• Rajni Kannan, BS, MS, RN, ANP-BC, Nurse Practitioner, NYU Cancer Institute, NYU Langone Medical Center, discusses the importance of educating patients ......More »

• Phase I Clinical Trial of AntiPD1 in Hematologic Malignancy

• October 19, 2012
• Medical oncologist Alexander Lesokhin discusses a phase I clinical trial assessing anti-PD-1 immunotherapy in patients with relapsed or refractory ......More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!